Tema Oncology ETF (CANC)
NASDAQ: CANC · Real-Time Price · USD
35.09
-0.24 (-0.68%)
At close: Dec 5, 2025, 4:00 PM EST
35.09
0.00 (0.00%)
After-hours: Dec 5, 2025, 4:15 PM EST

CANC Holdings Information

CANC is an equity ETF with a total of 53 individual holdings. The top holdings are Revolution Medicines stock at 6.11%, Eli Lilly and Company at 5.07%, AstraZeneca at 4.36%, BridgeBio Pharma at 4.27%, and Roche Holding AG at 4.19%.

Total Holdings
25
Top 10 Percentage
42.10%
Asset Class
Equity
ETF Category
Health
Assets
101.44M
PE Ratio
20.39

Sector Allocation

Top 25 Holdings

No.SymbolName WeightShares
1RVMDRevolution Medicines, Inc.6.11%81,486
2LLYEli Lilly and Company5.07%5,087
3LON: AZNAstraZeneca PLC4.36%24,696
4BBIOBridgeBio Pharma, Inc.4.27%59,689
5RHHBYRoche Holding AG4.19%88,682
6SWX: NOVNNovartis AG4.11%31,705
7GMABGenmab A/S3.77%123,261
8COGTCogent Biosciences, Inc.3.57%94,526
9NUVLNuvalent, Inc.3.35%32,425
10EXELExelixis, Inc.3.30%77,704
11BMYBristol-Myers Squibb Company3.24%65,896
12JNJJohnson & Johnson3.03%15,311
13ABBVAbbVie Inc.2.89%12,986
14MRKMerck & Co., Inc.2.57%25,990
15ACLXArcellx, Inc.2.46%34,948
16CELCCelcuity Inc.2.39%24,747
17ONCBeOne Medicines AG2.34%7,179
18SNDXSyndax Pharmaceuticals, Inc.2.18%114,677
19AMGNAmgen Inc.2.10%6,308
20IDYAIDEAYA Biosciences, Inc.2.07%62,358
21GILDGilead Sciences, Inc.2.01%16,672
22NUVBNuvation Bio Inc.1.93%238,898
23LEGNLegend Biotech Corporation1.86%69,362
24ZYMEZymeworks Inc.1.71%67,539
25SMMTSummit Therapeutics Inc.1.51%85,163
Showing 25 of 53 holdings
Subscribe to see the full list
As of Dec 3, 2025